
Camurus AB
STO:CAMX

Camurus AB
Net Income (Common)
Camurus AB
Net Income (Common) Peer Comparison



Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
![]() |
Camurus AB
STO:CAMX
|
Net Income (Common)
kr223.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
Calliditas Therapeutics AB
STO:CALTX
|
Net Income (Common)
-kr524.8m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
![]() |
Orexo AB
STO:ORX
|
Net Income (Common)
-kr96.7m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
S
|
Swedencare AB (publ)
STO:SECARE
|
Net Income (Common)
kr76.2m
|
CAGR 3-Years
20%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
![]() |
IRLAB Therapeutics AB
STO:IRLAB A
|
Net Income (Common)
-kr177.8m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
I
|
InDex Pharmaceuticals Holding AB
STO:FLERIE
|
Net Income (Common)
-kr190.4m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
See Also
What is Camurus AB's Net Income (Common)?
Net Income (Common)
223.3m
SEK
Based on the financial report for Jun 30, 2024, Camurus AB's Net Income (Common) amounts to 223.3m SEK.
What is Camurus AB's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-45%
Over the last year, the Net Income (Common) growth was -45%.